Moderna
MRNA
#1020
Rank
A$29.13 B
Marketcap
$75.72
Share price
-2.95%
Change (1 day)
-33.90%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Net assets

Net assets on the balance sheet as of June 2024 : A$17.63 Billion

According to Moderna 's latest financial reports the company has A$17.63 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Moderna - Net assets on balance sheet (from 2017 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$A$20.33 B-27.64%
2022-12-31$A$28.10 B44.03%
2021-12-31$A$19.51 B485.81%
2020-12-31$A$3.33 B98.49%
2019-12-31$A$1.67 B-22.75%
2018-12-31$A$2.17 B171.2%
2017-12-31$A$0.80 B-31.42%
2016-12-31$A$1.16 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
A$0.14 B-99.16%๐Ÿ‡บ๐Ÿ‡ธ USA
A$65.72 B 272.68%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$54.81 Million-100.31%๐Ÿ‡บ๐Ÿ‡ธ USA
A$48.72 M-99.72%๐Ÿ‡บ๐Ÿ‡ธ USA
A$65.41 B 270.91%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$0.51 B-97.11%๐Ÿ‡บ๐Ÿ‡ธ USA
A$105.65 B 499.03%๐Ÿ‡บ๐Ÿ‡ธ USA